Showing results (1451-1460 of 2,564) with videos related to

Sort By:
Pageof 257
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|November 20, 2019
Quality of Life in Patients with Reconstructions After Resections for Oral Cavity CancersSourabha K Patro, Naresh K Panda, Jaimanti Bakshi, et al.
Regional Anesthesia and Pain Medicine|December 21, 2019
Initial validation of the electronic form of the Michigan Body MapAfton L Hassett, Jennifer Pierce, Jenna Goesling, et al.
The National Medical Journal of India|March 10, 2009
Fludarabine in lymphoproliferative malignancies: a single-centre experienceK Prabhash, G S Vikram, R Nair, et al.
Journal of Neurology|September 6, 2024
The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosisAlexis M Callen, Jonathan Zurawski, Renxin Chu, et al.
Anesthesiology|January 14, 2015
Enhanced effects of isoflurane on the long QT syndrome 1-associated A341V mutantIkuomi Mikuni, Carlos G Torres, Tania Bakshi, et al.
Therapeutic Advances in Neurological Disorders|March 24, 2016
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough diseaseSteven J Greenberg, Robert Zivadinov, Peterkin Lee-Kwen, et al.
Frontiers in Microbiology|July 28, 2017
Piriformospora indica Reprograms Gene Expression in Arabidopsis Phosphate Metabolism Mutants But Does Not Compensate for Phosphate LimitationMadhunita Bakshi, Irena Sherameti, Doreen Meichsner, et al.
Molecular Microbiology|May 21, 2016
Elucidation of a mechanism of oxidative stress regulation in Francisella tularensis live vaccine strainZhuo Ma, Vincenzo C Russo, Seham M Rabadi, et al.
Cancer|September 1, 1979
Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazineA M Avellanosa, C R West, Y Tsukada, et al.
Therapeutic Advances in Neurological Disorders|April 29, 2017
Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trialRegina Berkovich, Rohit Bakshi, Lilyana Amezcua, et al.
Pageof 257